Current and potential applications of clinical 13C MR spectroscopy

Journal of Nuclear Medicine

Volumn 49, Issue 3, 2008, Pages 341-344

  Kurhanewicz, John ^a   Bok, Robert ^a   Nelson, Sarah J ^a   Vigneron, Daniel B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

13C; Magnetic resonance; Molecular imaging; MRI; Spectroscopy

Indexed keywords

CARBON NUCLEAR MAGNETIC RESONANCE; FOOD AND DRUG ADMINISTRATION; HYPERPOLARIZATION; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO;

CARBON ISOTOPES; FORECASTING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOLECULAR PROBE TECHNIQUES; PHYSICIAN'S PRACTICE PATTERNS; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; UNITED STATES;

EID: 40449116150     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.045112     Document Type: Review

References (25)

1. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging. 2002;16:451-463.
2. Rajesh A, Coakley FV, Kurhanewicz J. 3D MR spectroscopic imaging in the evaluation of prostate cancer. Clin Radiol. 2007;62:921-929.
3. Overhauser A. Paramagnetic relaxation in metals. Phys Rev. 1953;89:689.
4. 13C]-NMR spectroscopy of cerebral metabolism. NMR Biomed. 2003;16:339-357.
5. 13C NMR spectroscopy of the brain. NMR Biomed. 2003;16:313-338.
6. 13C MRS in vivo. NMR Biomed. 2003;16:358-369.
7. Rothman DL, Behar KL, Hyder F, Shulman RG. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol. 2003;65:401-427.
8. 13C NMR spectroscopy. Magn Reson Med. 1988;7:384-411.
9. 13C NMR spectroscopy of the human prostate. Magn Reson Med. 1988;8:224-230.
10. 13C imaging/spectroscopy by polarization transfer. Magn Reson Med. 1990;15:102-111.
11. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci USA. 2003;100:10158-10163.
12. 13C. Br J Radiol. 2003;76(spec no 2):S118-S127.
13. Wolber J, Ellner F, Fridlund B, et al. Generating highly polarized nuclear spins in solution using dynamic nuclear polarization. Nucl Instrum Methods Phys Res A. 2004;526:173-181.
14. Costello LC, Franklin RB. "Why do tumour cells glycolyse?": from glycolysis through citrate to lipogenesis. Mol Cell Biochem. 2005;280:1-8.
15. Gillies RJ, Gatenby RA. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr. 2007;39:251-257.
16. Costello LC, Franklin RB. Citrate metabolism of normal and malignant prostate epithelial cells. Urology. 1997;50:3-12.
17. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66:5977-5980.
18. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care. 2006;9:358-365.
19. 13C-1-pyruvate. Magn Reson Med. 2007;58:65-69.
20. Chen AP, Albers MJ, Cunningham CH, et al. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T: initial experience. Magn Reson Med. 2007;58:1099-1106.
21. 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 2006;66:10855-10860.
22. 1HHR-MAS spectroscopy of biopsies. Paper presented at: Joint Annual Meeting ISMRM-ESMRMB; May 19-25, 2007; Berlin, Germany.
23. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891-899.
24. Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer. 2003;97:1015-1024.
25. Warburg O, Wind F, Negelein E. Über den Stoffwechsel von Tumoren im Körper. Klin Woch. 1926;5:829-832.